• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.14% Nasdaq Down 0.35%

    More On GENE

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    Genetic Technologies Limited (GENE)

    -NasdaqCM
    2.33 Down 0.01(0.43%) Sep 3, 3:59PM EDT
    Add to Portfolio
    Prev Close:2.34
    Open:2.36
    Bid:1.00 x 200
    Ask:2.48 x 500
    1y Target Est:12.50
    Beta:2.30448
    Next Earnings Date:N/A
    Day's Range:2.31 - 2.44
    52wk Range:1.04 - 11.00
    Volume:96,426
    Avg Vol (3m):428,188
    Market Cap:13.18M
    P/E (ttm):N/A
    EPS (ttm):-1.50
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GENE

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.90
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-16) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Genetic Technologies Limited provides genetic testing services primarily in Australia and the United States. It offers a range of genetic tests for breast and ovarian cancer, bowel and uterine cancer, and prostate cancer; neurogenetic diagnostic a... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback